La référence en hépatite C au Québec depuis 2003

Hepatitis C : First once daily pan-genotipic regimen available in Canada

Published by CAPAHC on


Epclusa, is the first once daily hep C treatment regardless of genotype.

This cockail with (sofosbuvir 400mg + Velpatasvir 100mg) is a 12 weeks treatment with or without ribavirine (according to patient’s condition), the succes is about 83 to 98%.according to the presence or no-presence of cirrhosis and the gravity.